These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The rate of adenocarcinoma in endoscopically removed colorectal polyps. Odom SR; Duffy SD; Barone JE; Ghevariya V; McClane SJ Am Surg; 2005 Dec; 71(12):1024-6. PubMed ID: 16447472 [TBL] [Abstract][Full Text] [Related]
27. Detection of colorectal adenomas by routine chromoendoscopy with indigocarmine. Lee JH; Kim JW; Cho YK; Sohn CI; Jeon WK; Kim BI; Cho EY Am J Gastroenterol; 2003 Jun; 98(6):1284-8. PubMed ID: 12818270 [TBL] [Abstract][Full Text] [Related]
28. Frequency of colorectal polyps in patients with sporadic adenomas or adenocarcinomas of the papilla of vater--an age-matched, controlled study. Schneider AR; Seifert H; Trojan J; Stein J; Hoepffner NM Z Gastroenterol; 2005 Oct; 43(10):1123-7. PubMed ID: 16220451 [TBL] [Abstract][Full Text] [Related]
29. Differential diagnosis of adenomas and dysplastic lesions in patients with ulcerative colitis. Schneider A; Stolte M Z Gastroenterol; 1993 Nov; 31(11):653-6. PubMed ID: 8291276 [TBL] [Abstract][Full Text] [Related]
30. Histological assessment of colorectal adenomas by size. Are polyps less than 10 mm in size clinically important? Aldridge AJ; Simson JN Eur J Surg; 2001 Oct; 167(10):777-81. PubMed ID: 11775731 [TBL] [Abstract][Full Text] [Related]
31. [Colorectal precancerous conditions from the morphologic viewpoint]. Machnik G; Schneider A Dtsch Z Verdau Stoffwechselkr; 1985; 45(5):215-27. PubMed ID: 4085391 [TBL] [Abstract][Full Text] [Related]
32. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Engelhardt M; Drullinsky P; Guillem J; Moore MA Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582 [TBL] [Abstract][Full Text] [Related]
33. Colonoscopy surveillance in asymptomatic subjects with increased risk for colorectal cancer: clinical evaluation and cost analysis of an Italian experience. Matarese VG; Feo CV; Pezzoli A; Trevisani L; Brancaleoni M; Gullini S Eur J Cancer Prev; 2007 Aug; 16(4):292-7. PubMed ID: 17554201 [TBL] [Abstract][Full Text] [Related]
34. [Groups at risk for colorectal tumors]. Liebe S Z Gesamte Inn Med; 1990 Aug; 45(15):435-8. PubMed ID: 2174198 [TBL] [Abstract][Full Text] [Related]
35. [Colorectal cancer. Precancerous conditions]. Samec HJ Wien Med Wochenschr; 1988 Jun; 138(11-12):285-7. PubMed ID: 3051689 [TBL] [Abstract][Full Text] [Related]
36. [Premalignant and malignant changes in idiopathic inflammatory bowel disease]. Knezević-Usaj S; Panisić M; Tarabar D; Cuk V; Brajuković G; Petrović M Acta Chir Iugosl; 2000; 47(1-2):43-50. PubMed ID: 10953365 [TBL] [Abstract][Full Text] [Related]
37. Congenital genetic instability in colorectal carcinomas. Svendsen LB Dan Med Bull; 1993 Nov; 40(5):546-56. PubMed ID: 8299399 [TBL] [Abstract][Full Text] [Related]
38. [Prevention and surveillance of risk groups for colorectal carcinoma]. Münch R Schweiz Rundsch Med Prax; 1992 Jun; 81(26):850-2. PubMed ID: 1320771 [TBL] [Abstract][Full Text] [Related]
39. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. Velayos FS; Loftus EV; Jess T; Harmsen WS; Bida J; Zinsmeister AR; Tremaine WJ; Sandborn WJ Gastroenterology; 2006 Jun; 130(7):1941-9. PubMed ID: 16762617 [TBL] [Abstract][Full Text] [Related]